
Reset all filters
01 3Smart & Biggar LLP
Reset all filters
01 32876689
Reset all filters
01 3PEMIGATINIB
Reset all filters
01 3TABLET
Reset all filters
01 32033-06-12
Patent Expiration Date : 2033-06-12
Date Granted : 2022-04-26
Brand Name : PEMAZYRE
Patent Number : 2876689
Filing Date : 2013-06-12
Strength per Unit : 4.5mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-06-12
Date Granted : 2022-04-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-06-12
Date Granted : 2022-04-26
Brand Name : PEMAZYRE
Patent Number : 2876689
Filing Date : 2013-06-12
Strength per Unit : 9mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-06-12
Date Granted : 2022-04-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-06-12
Date Granted : 2022-04-26
Brand Name : PEMAZYRE
Patent Number : 2876689
Filing Date : 2013-06-12
Strength per Unit : 13.5mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-06-12
Date Granted : 2022-04-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF